ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,595.76
0.75%
US Tech 100
18,933.41
1.01%
Dow Jones
41,096.77
0.58%
Brent Oil
72.07
0.14%
Bitcoin
57,955.92
-0.31%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Unicycive Therapeutics Inc (UNCY)

  7. Unicycive Therapeutics Inc (UNCY) News

UNCY

Unicycive Therapeutics (UNCY)

Unicycive Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:UNCY
DateTimeSourceHeadlineSymbolCompany
09/05/20247:03AMGlobeNewswire Inc.Unicycive Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
09/03/20247:03AMGlobeNewswire Inc.Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on DialysisNASDAQ:UNCYUnicycive Therapeutics Inc
08/26/20247:03AMGlobeNewswire Inc.Unicycive Therapeutics to Present Three Posters at the American Society of Nephrology (ASN) Kidney Week 2024NASDAQ:UNCYUnicycive Therapeutics Inc
08/14/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UNCYUnicycive Therapeutics Inc
08/14/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UNCYUnicycive Therapeutics Inc
08/14/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UNCYUnicycive Therapeutics Inc
08/14/20248:11AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
08/14/20247:10AMGlobeNewswire Inc.Unicycive Announces Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
08/14/20247:05AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:UNCYUnicycive Therapeutics Inc
07/17/20247:03AMGlobeNewswire Inc.Unicycive Therapeutics Granted Patent on UNI-494 to Treat Acute Kidney Injury by the United States Patent and Trademark Office (USPTO)NASDAQ:UNCYUnicycive Therapeutics Inc
07/17/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:UNCYUnicycive Therapeutics Inc
07/16/202410:31AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:UNCYUnicycive Therapeutics Inc
07/15/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
07/15/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
07/11/20247:03AMGlobeNewswire Inc.Unicycive Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 3rd Annual Kidney Virtual ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
07/10/20247:03AMGlobeNewswire Inc.Unicycive Therapeutics Announces Initial Positive Patient Satisfaction Findings from Pivotal Clinical Trial of Oxylanthanum Carbonate (OLC)NASDAQ:UNCYUnicycive Therapeutics Inc
07/01/20247:03AMGlobeNewswire Inc.Unicycive Therapeutics Joins Russell Microcap® IndexNASDAQ:UNCYUnicycive Therapeutics Inc
06/25/20247:30AMGlobeNewswire Inc.Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical TrialNASDAQ:UNCYUnicycive Therapeutics Inc
05/28/20247:03AMGlobeNewswire Inc.Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association CongressNASDAQ:UNCYUnicycive Therapeutics Inc
05/23/20247:03AMGlobeNewswire Inc.Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
05/15/20247:03AMGlobeNewswire Inc.Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical MeetingNASDAQ:UNCYUnicycive Therapeutics Inc
05/13/20244:28PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
05/13/20244:16PMGlobeNewswire Inc.Unicycive Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
05/13/20244:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:UNCYUnicycive Therapeutics Inc
05/08/20244:05PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:UNCYUnicycive Therapeutics Inc
04/10/20247:03AMGlobeNewswire Inc.Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
03/28/20244:15PMGlobeNewswire Inc.Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
03/25/20247:03AMGlobeNewswire Inc.Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association CongressNASDAQ:UNCYUnicycive Therapeutics Inc
03/14/20247:03AMGlobeNewswire Inc.Unicycive Announces $50 Million Private PlacementNASDAQ:UNCYUnicycive Therapeutics Inc
03/13/20247:03AMGlobeNewswire Inc.Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:UNCY

Your Recent History

TG
LB39DQ
Landesbank Baden Wurttem...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved